GLAD:NASDAQGladstone Capital Corporation Analysis
Data as of 2026-04-06 - not real-time
$17.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Gladstone Capital (GLAD) trades near $17.90, well above its DCF‑derived fair value of roughly $11.20, indicating the market is pricing in a premium despite modest revenue growth of 11.6% and a strong dividend yield of over 10%. Technical indicators show a bearish bias: the price sits below the 20‑day SMA (17.63) and the 50‑day SMA (18.59), the 200‑day SMA remains at $22.09, and the MACD line is negative though the histogram has turned slightly positive, suggesting limited upside momentum. The RSI at 50.5 points to a neutral stance, while volume is increasing, supporting the current price level but not enough to reverse the downtrend. Fundamentally, the company’s P/E of 11.3 is below the industry average of 16.6, yet the high payout ratio of 122% raises concerns about dividend sustainability, especially given negative operating cash flow and a debt‑to‑equity ratio above 80%. The balance sheet shows $405.9 M of debt versus $4.2 M of cash, creating leverage risk. Volatility is elevated at 27.7% over the past 30 days, though beta is modest at 0.81, reflecting lower systematic risk but higher idiosyncratic risk. The stock’s upside potential from the DCF model is roughly 21%, yet the current market sentiment is “Extreme Greed,” which may be overstating near‑term expectations. Overall, GLAD appears overvalued relative to intrinsic estimates, with a dividend that may be unsustainable and a bearish technical outlook, suggesting caution for investors.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- price below short‑term moving averages
- bearish technical trend
- unsustainable dividend payout
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- moderate revenue growth
- valuation gap between market price and DCF
- high leverage and cash flow concerns
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- potential for dividend adjustments improving sustainability
- stable sector fundamentals for BDCs
- ongoing credit risk from high debt levels
Key Metrics & Analysis
Financial Health
Revenue Growth11.60%
Profit Margin38.91%
P/E Ratio11.3
ROE7.16%
ROA4.96%
Debt/Equity80.14
P/B Ratio0.8
Op. Cash Flow$-63284000
Free Cash Flow$29.7M
Industry P/E16.6
Technical Analysis
TrendBearish
RSI50.5
Support$16.54
Resistance$18.34
MA 20$17.63
MA 50$18.59
MA 200$22.09
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair Value$11.20
Target Price$21.67
Upside/Downside21.04%
GradeOvervalued
TypeValue
Dividend Yield10.55%
Risk Assessment
Beta0.81
Volatility27.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.